🇪🇸 Spain · EU Public Tender
Suministro de los principios activos denominados "Faricimab 28,8 MG / 0,24 ML VIAL 0,24 ML Intravitrea" Y "Polatuzumab Vedotina 30MG POLVO PERFUSION".
🏛️ Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín · 📍 Las Palmas de Gran Canaria
487 K€
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33690000 |
| Awarded to | Roche Farma, S.A. |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.